FR2601875B1 - Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol - Google Patents

Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol

Info

Publication number
FR2601875B1
FR2601875B1 FR878710367A FR8710367A FR2601875B1 FR 2601875 B1 FR2601875 B1 FR 2601875B1 FR 878710367 A FR878710367 A FR 878710367A FR 8710367 A FR8710367 A FR 8710367A FR 2601875 B1 FR2601875 B1 FR 2601875B1
Authority
FR
France
Prior art keywords
cysteine
sorbitol
acetyl
water
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR878710367A
Other languages
English (en)
French (fr)
Other versions
FR2601875A1 (fr
Inventor
Annibale Gazzaniga
Valter Gianesello
Federico Stroppolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inpharzam International SA
Original Assignee
Inpharzam International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharzam International SA filed Critical Inpharzam International SA
Publication of FR2601875A1 publication Critical patent/FR2601875A1/fr
Application granted granted Critical
Publication of FR2601875B1 publication Critical patent/FR2601875B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR878710367A 1986-07-24 1987-07-22 Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol Expired - Lifetime FR2601875B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2974/86A CH666814A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.

Publications (2)

Publication Number Publication Date
FR2601875A1 FR2601875A1 (fr) 1988-01-29
FR2601875B1 true FR2601875B1 (fr) 1992-02-21

Family

ID=4245819

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878710367A Expired - Lifetime FR2601875B1 (fr) 1986-07-24 1987-07-22 Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol

Country Status (8)

Country Link
BE (1) BE1000168A3 (it)
CH (1) CH666814A5 (it)
DE (1) DE3723734A1 (it)
FR (1) FR2601875B1 (it)
GB (1) GB2192789B (it)
IT (1) IT1222103B (it)
NL (1) NL194154C (it)
SE (1) SE500493C2 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
CH674940A5 (it) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
DE3909049A1 (de) * 1989-03-18 1990-09-20 Arthur Boskamp Praeparat und dessen verwendung
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
DE4406261C2 (de) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge
DE4329857C2 (de) * 1993-09-03 1995-08-24 Deutsches Krebsforsch Verbindung zur Stärkung des Immunsystems und von Immunreaktionen
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
WO2000018392A1 (en) 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
AU772616B2 (en) 1998-09-25 2004-05-06 Protemix Corporation Limited Fructosamine oxidase assay: methods and materials
EP1293251A1 (en) * 2001-09-14 2003-03-19 Holland Sweetener Company V.o.F. Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder
AU2003225442B2 (en) 2002-03-08 2010-02-04 Philera New Zealand Limited Preventing and/or treating cardiovascular disease and/or associated heart failure
EP1539129A4 (en) 2002-08-20 2006-03-08 Protemix Corp Ltd DOSAGE FORMS AND RELEVANT THERAPIES
PT1778618E (pt) 2004-07-19 2014-03-04 Philera New Zealand Ltd Síntese de trietilenotetraminas
GR1007236B (el) * 2009-12-07 2011-04-08 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Νεα φαρμακευτικη συνθεση κοκκιων ν - ακετυλοκυστεϊνης και μεθοδος παραγωγης αυτων
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN103142505B (zh) * 2013-03-29 2015-03-11 山东罗欣药业集团股份有限公司 一种乙酰半胱氨酸组合物颗粒剂及其制备方法
ES2877679T3 (es) 2017-12-31 2021-11-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composición farmacéutica que comprende acetilcitisteína sin metilparabeno ni propilparabeno
CN113559078A (zh) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617638A1 (de) * 1967-05-24 1971-05-13 Miles Lab Tablettenbindemittel
CH646843A5 (en) * 1982-02-17 1984-12-28 Xyrofin Ag Sugar substitute, method for its production, and its use
DE3317558A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Orales antischnarchmittel
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
IT1170268B (it) * 1983-12-21 1987-06-03 Zambon Spa Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi
DE3514995A1 (de) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut

Also Published As

Publication number Publication date
SE500493C2 (sv) 1994-07-04
SE8702941D0 (sv) 1987-07-23
DE3723734C2 (it) 1992-05-21
DE3723734A1 (de) 1988-02-04
NL8701744A (nl) 1988-02-16
CH666814A5 (it) 1988-08-31
BE1000168A3 (fr) 1988-07-05
IT1222103B (it) 1990-08-31
FR2601875A1 (fr) 1988-01-29
GB2192789B (en) 1990-01-31
NL194154B (nl) 2001-04-02
IT8721410A0 (it) 1987-07-23
SE8702941L (sv) 1988-01-25
NL194154C (nl) 2001-08-03
GB8717581D0 (en) 1987-09-03
GB2192789A (en) 1988-01-27

Similar Documents

Publication Publication Date Title
FR2601875B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol
FR2601876B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2604357B1 (fr) Composition pharmaceutique et cosmetique anti-acneique
FR2602974B1 (fr) Composition pharmaceutique contenant de la nicotine ou ses derives
MC1782A1 (fr) Preparation pharmaceutique
IT1219941B (it) Composizioni farmaceutiche contenenenti cefuroxima axetil e procedimento per prepararle
FR2596758B1 (fr) Sels pharmaceutiques d'amlodipine ameliores et compositions pharmaceutiques les contenant
FR2430410B1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
FR2626002B1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
FR2645152B1 (fr) 3h-pteridinones-4, procedes de preparation et medicaments les contenant
FR2596651B1 (fr) Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant
BE888797A (fr) Derives de carnitine et compositions pharmaceutiques en contenant
FR2608921B1 (fr) Composition pharmaceutique contenant de la ranitidine
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
FR2598617B1 (fr) Composition pharmaceutique
FR2618333B1 (fr) Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
PT84933B (fr) Procede de preparation de cyclodepsipeptides et compositions pharmaceutiques qui les contiennent
PT82364A (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
FR2634764B1 (fr) Heterocycles oxaza et compositions pharmaceutiques les contenant
FR2512822B1 (fr) Derives de l'antibiotique tylosine et compositions pharmaceutiques les contenant
PT82853A (fr) Procede de preparation de nouveaux benzamides et des compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name